0001628280-22-026400.txt : 20221014
0001628280-22-026400.hdr.sgml : 20221014
20221014142702
ACCESSION NUMBER: 0001628280-22-026400
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221012
FILED AS OF DATE: 20221014
DATE AS OF CHANGE: 20221014
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: SIDRANSKY DAVID
CENTRAL INDEX KEY: 0001277161
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-11504
FILM NUMBER: 221311042
MAIL ADDRESS:
STREET 1: JOHNS HOPKINS UNIVERSITY
STREET 2: 720 RUTLAND AVENUE
CITY: BALTIMORE
STATE: MD
ZIP: 21205
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CHAMPIONS ONCOLOGY, INC.
CENTRAL INDEX KEY: 0000771856
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
IRS NUMBER: 521401755
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0430
BUSINESS ADDRESS:
STREET 1: 855 N. WOLFE STREET
STREET 2: SUITE 619
CITY: BALTIMORE
STATE: MD
ZIP: 21205
BUSINESS PHONE: 410-369-0365
MAIL ADDRESS:
STREET 1: 855 N. WOLFE STREET
STREET 2: SUITE 619
CITY: BALTIMORE
STATE: MD
ZIP: 21205
FORMER COMPANY:
FORMER CONFORMED NAME: CHAMPIONS BIOTECHNOLOGY, INC.
DATE OF NAME CHANGE: 20070220
FORMER COMPANY:
FORMER CONFORMED NAME: CHAMPIONS SPORTS INC
DATE OF NAME CHANGE: 19920703
FORMER COMPANY:
FORMER CONFORMED NAME: INTERNATIONAL GROUP INC
DATE OF NAME CHANGE: 19860319
4
1
wf-form4_166577200797332.xml
FORM 4
X0306
4
2022-10-12
0
0000771856
CHAMPIONS ONCOLOGY, INC.
CSBR
0001277161
SIDRANSKY DAVID
C/O CHAMPIONS ONCOLOGY, INC.
ONE UNIVERSITY PLAZA, SUITE 307
HACKENSACK
NJ
07601
1
0
0
0
Common Stock
2022-10-12
4
M
0
8333
3.21
A
770605
D
Common Stock
2022-10-12
4
F
0
3562
7.51
D
767043
D
Option to purchase Common Stock
3.21
2022-10-12
4
M
0
8333
0
D
2022-10-31
Common Stock
8333.0
0
D
Represents a "net exercise" of outstanding stock opitons. These shares were witheld by Champions Oncology, Inc. for payment of the exercise price based on the market price of Champions Oncology, common stock on October 12, 2022.
The options vest and are exercisable over a twelve month period, with vesting to occur on November 8, 2017, February 8, 2018, May 8, 2018 and August 8, 2018
/s/ David Sidransky
2022-10-12